Heather Stringer

The use of newer tools and techniques may be reducing the risk of surgical site infections and other complications in patients receiving treatment for gynecologic cancers.

Significant challenges include improving detection and response to inner ear side effects among cancer survivors following the use of certain drugs and therapies.

A new technology that can detect small amounts of circulating tumor DNA in the blood of patients who previously received a diagnosis of certain types of cancer may dramatically accelerate the ability to cure more patients, says an expert from the University of Texas MD Anderson Cancer Center.

The identification of rare genomic alterations in patients with colorectal cancer gives oncologists the opportunity to treat patients who otherwise might not have many options.

Nonalcoholic fatty liver disease can lead to cancer. Patients can reverse the damage through diet and exercise, but how can they know if they have the common condition?

New treatments are lengthening life and improving its quality for some with metastatic breast cancer.

Immunotherapy takes on a new role in treating patients with triple-negative disease.

Patients with head and neck cancer may soon have more effective, less toxic choices as immunotherapy moves into first-line treatment and novel targeted drugs are explored.

Patients with multiple myeloma find relief from side effects, thanks to newer drug combinations.

Treatments with PARP inhibitors and immunotherapies are helping patients with small cell lung cancer live better and longer.

Injectable forms of medication may benefit patients with blood cancers.

Recent studies that suggest meditation can reduce the perception of pain in adults have prompted researchers to explore whether it could provide pain relief for children with neuroblastoma.